24 results on '"Patel, Parul"'
Search Results
2. Efficacy, Safety, and Pharmacokinetics by Body Mass Index Category in Phase 3/3b Long-Acting Cabotegravir Plus Rilpivirine Trials
3. 1586. Phase 3/3b Experience with Long-Acting Cabotegravir and Rilpivirine: Efficacy and Safety Outcomes Through Week 96 by Race
4. 877. North American Phase 3/3b Experience with Long-Acting Cabotegravir and Rilpivirine: Efficacy, Safety, and Virologic Outcomes
5. 885. Pregnancy Outcomes and Pharmacokinetics in Pregnant Women Living with HIV Exposed to Long-Acting Cabotegravir and Rilpivirine in Clinical Trials
6. LB-8. Summary of COVID-Related Impact on Cabotegravir and Rilpivirine Long-Acting (CAB+RPV LA) Dosing Across the Six Ongoing Global Phase IIb and IIIb Clinical Trials
7. 1029. Long-Term Patient Adherence and Management of Treatment Interruptions With Long-Acting Injectable Cabotegravir + Rilpivirine for Maintenance Therapy in Phase IIb/III Studies
8. Evaluation of the effect of UGT1A1 polymorphisms on the pharmacokinetics of oral and long-acting injectable cabotegravir
9. Pharmacokinetics and antiviral activity of cabotegravir and rilpivirine in cerebrospinal fluid following long-acting injectable administration in HIV-infected adults
10. 1687. High-Rates of Candida auris Carriage and Co-Colonization with Multidrug-Resistant Organisms (MDROs)
11. 2495. Pharmacokinetics of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injectables in HIV-infected Individuals through 48 Weeks in the FLAIR and ATLAS Phase 3 Studies
12. 2152. Detection of Uropathogens Using BD Kiestra™ Total Laboratory Automation with Urine Culture Application
13. 1532. Population Pharmacokinetic (PPK) Modeling and Simulation of Long-Acting (LA) Cabotegravir (CAB) to Inform Strategies Following Dosing Interruptions in HIV-1-Infected Subjects
14. 552. Evaluation of Relationships Between UGT1A1 Genotypes and Cabotegravir Long-Acting Injection Pharmacokinetics Among HIV-Infected Subjects in the LATTE-2 Study
15. High Prevalence of Multidrug-resistant Organisms: MRSA, VRE, CRE, ESBLs, and C. difficile at a Chicago LTACH
16. Pharmacokinetics of Cabotegravir in Subjects with Moderate Hepatic Impairment
17. Pharmacokinetics of Cabotegravir in Subjects with Severe Renal Impairment
18. Cabotegravir(CAB) Safety Meta-analysis Update from 14 Phase I/IIa Studies
19. Evaluation of Multiple Real-Time PCR Tests on Nasal Samples in a Large MRSA Surveillance Program
20. Performance of the SteriPath Device in Removing Skin Contamination From Blood Culture Samples
21. 866Observational Study of Central Venous Catheter (CVC) Occlusions and Central Line-Associated Blood Stream Infections (CLABSI) Using the Clave™ Negative Displacement Connector
22. 637Control of Methicillin-Resistant Staphylococcus aureus (MRSA) in Long Term Care is Possible While Maintaining Patient Socialization without Isolation
23. The Use of Rat Lens Explant Cultures to Study the Mechanism of Drug-Induced Cataractogenesis
24. Laboratory Testing for Clostridium difficile Infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.